We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $145B
1-Year Est. Return 34.61%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+34.61%
3 Year Est. Return
+158.21%
5 Year Est. Return
+226.99%
10 Year Est. Return
+1,390.17%
AUM
$95.4B
AUM Growth
+$6.5B
Cap. Flow
-$3.46B
Cap. Flow %
-3.62%
Top 10 Hldgs %
19.44%
Holding
756
New
84
Increased
239
Reduced
326
Closed
76

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$677M
2
ISRG icon
Intuitive Surgical
ISRG
+$501M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$476M
4
CCI icon
Crown Castle
CCI
+$365M
5
RL icon
Ralph Lauren
RL
+$336M

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Consumer Discretionary 14.62%
3 Technology 10.39%
4 Communication Services 9.8%
5 Energy 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
501
Precigen
PGEN
$1.94B
$5.33M 0.01%
+235,425
New +$5.43M
GBCI icon
502
Glacier Bancorp
GBCI
$6.36B
$5.29M 0.01%
214,247
-19,825
-8% -$475K
OREX
503
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.13M 0.01%
83,559
CMRX
504
DELISTED
Chimerix, Inc.
CMRX
$5.12M 0.01%
232,788
-917
-0.4% -$18.9K
TRAK
505
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$5.07M 0.01%
118,330
-842
-0.7% -$33.3K
VNDA icon
506
Vanda Pharmaceuticals
VNDA
$304M
$4.94M 0.01%
+450,000
New +$4.81M
XNPT
507
DELISTED
XENOPORT, INC.
XNPT
$4.92M 0.01%
865,539
+18,733
+2% +$97.7K
AGIO icon
508
Agios Pharmaceuticals
AGIO
$2.08B
$4.89M 0.01%
+175,000
New +$4.83M
MXT
509
DELISTED
MAXCOM TELECOMUNICACIONES S A DE C V SPONSORED ADR REP (MX)
MXT
$4.78M 0.01%
1,706,000
AENZ
510
DELISTED
Aenza S.A.A.
AENZ
$4.6M ﹤0.01%
+76,824
New +$4.76M
TRNX
511
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.58M ﹤0.01%
237,049
XPRO icon
512
Expro Ltd
XPRO
$1.66B
$4.49M ﹤0.01%
+25,000
New +$4.21M
MGLN
513
DELISTED
Magellan Health Services, Inc.
MGLN
$4.46M ﹤0.01%
74,402
-60
-0.1% -$3.48K
TEN
514
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$4.15M ﹤0.01%
82,102
+6,239
+8% +$304K
NSPR icon
515
InspireMD
NSPR
$31.4M
0
SFG
516
DELISTED
STANCORP FINL GRP
SFG
$3.97M ﹤0.01%
72,153
-422,525
-85% -$22.6M
TRP icon
517
TC Energy
TRP
$70.1B
$3.87M ﹤0.01%
88,095
+1,131
+1% +$50.4K
IDIX
518
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$3.83M ﹤0.01%
735,742
GYRE icon
519
Gyre Therapeutics
GYRE
$629M
$3.69M ﹤0.01%
882
ROG icon
520
Rogers Corp
ROG
$2.08B
$3.67M ﹤0.01%
61,790
-96
-0.2% -$5.26K
NAK
521
Northern Dynasty Minerals
NAK
$773M
$3.58M ﹤0.01%
2,454,438
+107
+0% +$222
PIPR icon
522
Piper Sandler
PIPR
$4.99B
$3.53M ﹤0.01%
412,108
+73,500
+22% +$619K
LUV icon
523
Southwest Airlines
LUV
$21.7B
$3.46M ﹤0.01%
237,779
+25,007
+12% +$340K
ITW icon
524
Illinois Tool Works
ITW
$84.1B
$3.42M ﹤0.01%
+44,912
New +$3.28M
CORT icon
525
Corcept Therapeutics
CORT
$9.98B
$3.4M ﹤0.01%
2,136,749

Similar funds

Jennison Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Jennison Associates held 756 positions worth $95.4B, up 7.3% from $88.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jennison Associates withdrew a net $3.46B in Q3 2013, closing 76 positions and reducing 326 holdings. Its most notable exit was Intuitive Surgical, an estimated $501M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Jennison Associates opened a new position in Under Armour worth $157M.

  • Jennison Associates's largest Q3 2013 buy was Under Armour: 7,942,523 shares worth $157M.
  • Jennison Associates added most to Capri Holdings in Q3 2013, an estimated $448M increase.
  • Jennison Associates's biggest Q3 2013 reduction was IBM, cutting an estimated $677M.
  • Jennison Associates fully exited Intuitive Surgical in Q3 2013, selling an estimated $501M.
  • Jennison Associates's ten largest holdings make up 19% of its $95.4B portfolio in Q3 2013.
  • Jennison Associates opened 84 new positions and closed 76 in Q3 2013.
  • Jennison Associates's portfolio value rose 7.3% quarter-over-quarter to $95.4B.

Based on Jennison Associates's 13F filing for Q3 2013, filed 13 Nov 2013.